NO944991D0 - Sukkerbelagt farmasöytisk doseringsenhet - Google Patents

Sukkerbelagt farmasöytisk doseringsenhet

Info

Publication number
NO944991D0
NO944991D0 NO944991A NO944991A NO944991D0 NO 944991 D0 NO944991 D0 NO 944991D0 NO 944991 A NO944991 A NO 944991A NO 944991 A NO944991 A NO 944991A NO 944991 D0 NO944991 D0 NO 944991D0
Authority
NO
Norway
Prior art keywords
dosing unit
sugar coated
coated pharmaceutical
pharmaceutical dosing
sugar
Prior art date
Application number
NO944991A
Other languages
English (en)
Other versions
NO944991L (no
NO305273B1 (no
Inventor
Pieter De Haan
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO944991D0 publication Critical patent/NO944991D0/no
Publication of NO944991L publication Critical patent/NO944991L/no
Publication of NO305273B1 publication Critical patent/NO305273B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO944991A 1993-12-23 1994-12-22 Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse derav NO305273B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (3)

Publication Number Publication Date
NO944991D0 true NO944991D0 (no) 1994-12-22
NO944991L NO944991L (no) 1995-06-26
NO305273B1 NO305273B1 (no) 1999-05-03

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944991A NO305273B1 (no) 1993-12-23 1994-12-22 Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse derav

Country Status (16)

Country Link
US (1) US5662936A (no)
EP (1) EP0659432B1 (no)
JP (1) JPH07206681A (no)
KR (1) KR100330560B1 (no)
CN (1) CN1108929A (no)
AT (1) ATE155039T1 (no)
AU (1) AU685538B2 (no)
CA (1) CA2138451C (no)
DE (2) DE69404116T2 (no)
DK (1) DK0659432T3 (no)
ES (1) ES2105501T3 (no)
FI (1) FI116035B (no)
GR (1) GR3024817T3 (no)
NO (1) NO305273B1 (no)
NZ (1) NZ270228A (no)
ZA (1) ZA949929B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
ES2218556T3 (es) * 1994-11-22 2004-11-16 Balance Pharmaceuticals, Inc. Metodos de contracepcion.
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP0927556B1 (en) * 1997-09-23 2000-08-30 Akzo Nobel N.V. Dosage units of steroids with a seal coating for the steroids
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
WO2001027210A1 (en) * 1999-10-11 2001-04-19 Ml Laboratories Plc Medicament delivery device with moisture resistant coating
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
AU4278301A (en) * 2000-03-27 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Easy-to-take granule
WO2001087272A2 (en) * 2000-05-18 2001-11-22 Therics, Inc. Encapsulating a toxic core within a non-toxic region in an oral dosage form
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
BRPI0509348A (pt) 2004-04-21 2007-09-11 Innovata Biomed Ltd inalador
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE602005023193D1 (de) * 2004-10-15 2010-10-07 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
RU2013135273A (ru) * 2010-12-29 2015-02-10 Нестек С.А. Кондитерский продукт, содержащий агломерированный масляный порошок
WO2014006084A1 (en) * 2012-07-03 2014-01-09 Nestec S.A. Confectionery product comprising agglomerated oil powder
CA2892023A1 (en) * 2012-11-22 2014-05-30 Evonik Rohm Gmbh Process for preparing a granulated product from a powder composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
AU8168494A (en) 1995-06-29
CA2138451C (en) 2007-04-24
CN1108929A (zh) 1995-09-27
FI946043A (fi) 1995-06-24
US5662936A (en) 1997-09-02
FI116035B (fi) 2005-09-15
DK0659432T3 (da) 1998-02-16
CA2138451A1 (en) 1995-06-24
NO944991L (no) 1995-06-26
GR3024817T3 (en) 1998-01-30
AU685538B2 (en) 1998-01-22
DE69404116D1 (de) 1997-08-14
DE659432T1 (de) 1997-01-30
ES2105501T3 (es) 1997-10-16
KR100330560B1 (ko) 2002-09-05
JPH07206681A (ja) 1995-08-08
NO305273B1 (no) 1999-05-03
ZA949929B (en) 1995-08-23
NZ270228A (en) 1995-09-26
DE69404116T2 (de) 1997-11-13
EP0659432A1 (en) 1995-06-28
EP0659432B1 (en) 1997-07-09
KR950016715A (ko) 1995-07-20
FI946043A0 (fi) 1994-12-22
ATE155039T1 (de) 1997-07-15

Similar Documents

Publication Publication Date Title
DK0659432T3 (da) Sukkerbelagt farmaceutisk doseringsenhed
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
AU5587690A (en) Treatment of postmenopausal disorders
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
IL65843A (en) Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
SE9303289D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
IL96814A0 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom,processes for the preparation thereof and pharmaceutical compositions containing them
FR2757512B1 (fr) Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
IT9048540A0 (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
NO950484D0 (no) 3- og 5-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, fremgangsmåte for fremstilling derav, farmasöytisk preparat inneholdende forbindelsene samt anvendelse av slike for fremstilling av medikamenter
MX9601659A (es) Antagonistas del receptor de adhesion, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades.
IL97715A0 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same
HU00224A9 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees